Clinical Trial Update: Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration [NA]

View source ↗

Summary

This clinical trial is recruiting to evaluate the use of stem cell-derived exosomes for treating melasma and to study their percutaneous skin penetration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Stem cell-derived exosomes

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Melasma | NA | Status: RECRUITING